Developed by physicians to provide a NO PAIN testing solution for glucose levels using saliva instead of finger-stick blood tests, the iQuickIt Saliva Analyzer offers a revolutionary solution for people with diabetes to manage their care.
We have developed our patent-pending device, tested the science and have a working prototype but we need your help to bring this product to consumers. Every contribution, no matter the size, will support this global initiative.
We've seen our family, our friends and our patients deal with the discomfort of daily blood glucose tests or suffer the effects of improper diabetes management. There is a better way and YOU can help make it happen.
It takes a significant amount of money to develop a medical device in the US. Our doctors, business team and software developers are a top notch, passionate group that want to get the iQuickIt Saliva Analyzer in your hands, or your mom's hands, or your neighbor's hands...we want to save hands from finger sticks!
Our goal - $100,000
This critical campaign goal will allow our medical team to test the iQuickIt Saliva Analyzer prototype with a larger field of patients with diabetes to compare results against blood tests and further develop, refine and calibrate the design. This extensive testing is a necessary next step within our funding goal levels to ultimately ensure the efficacy of the prototype and its design. With due diligence at each step, we are hopeful this tedious process will efficiently culminate in FDA testing and approval.
What's in it for you?
- Personal fulfillment of supporting your loved one, yourself or 371 million others to access better diabetes monitoring with NO PAIN.
- Really cool stuff to show off what a great person you are for supporting your loved one, yourself or 371 million others to access better diabetes monitoring with NO PAIN.
- Your name and picture in lights...or at least on the internet. We want to give you credit for supporting the cause! All non-anonymous supporters will be listed on our iQuickItSalivaAnalyzer.com "No Pain" page and those contributing $60 or more can have a picture and 140 characters included in our Thank You videos (more bragging rights).
Our campaign goal of $100,000 is step one. Our next funding goal of $1 million will help support additional engineering and modifications to the software and hardware interfaces, additional testing and quality controls. Beyond that goal, we will seek to raise funds to support the total projected cost to bring the iQuickIt Saliva Analyzer through the tedious FDA testing and approval process and to a production-ready product. We have a long way to go but we are committed to getting there and appreciate all of your efforts to help make that happen!
Join the NO PAIN cause on Facebook.com/QuickLLC
Show off your support by sharing your listing on the NO PAIN Wall of Support or your 30 seconds of fame in our Thank You video.
The Quick management team, pictured left to right here with Ella and Gary (the friendly people with diabetes in the cool video you just watched):
J. Scott Fox - President and Chief Executive Officer
David Mucci, M.D. - Chief Design and Technology Officer
Jeanne Mucci - Director of Project Management
Ron Clark, M.D., FACEP - Chief Strategy Officer
William A. Petit Jr., M.D. - Diabetes Advisor
We want to make sure you understand certain things before contributing to our indiegogo campaign. Quick, LLC, is a Connecticut limited liability company. All references to ”Quick,” as well as the words “we,” “our,” and words of similar import refer to Quick, LLC, and not any particular individual owner, member, manager, employee, consultant, or service provider of Quick, LLC, or any of their affiliates. The iQuickIt Salivia Analyzer prototype is a testing prototype only and is not ready for commercial production. The model featured in the video and in photos is a non-working model that is based on illustrations of our final design. It is shown for illustrative purposes only. There are many risks inherent in the development of our product and therefore no assurances of commercial viability. Risks include: the product not receiving FDA approval, sufficient funding not secured to complete testing, development, approval and commercialization.
With respect to the Quick Advisor perk, please note that the advisory board is an informal group of advisors that acts in a non-binding capacity at the pleasure of the Managers of Quick, LLC. Advisory board members are required to sign an advisory board member agreement as well as a nondisclosure, nonsoliciation, and noncompete agreement with Quick, LLC. You will not receive compensation for serving as an advisory board member. Advisory board members may be removed by the Managers of Quick, LLC at any time, for any reason. Admission to the advisory board and participation in advisory board activities is subject to the final approval of the Managers of Quick, LLC. The transportation and meal expenses provided by Quick, LLC, will be limited to domestic (USA) travel only and otherwise representing the least expensive alternative in accordance with policies to be communicated to the contributor by Quick, LLC.
Please note that our website generally, and, particularly, our “No Pain” webpage devoted to thanking our donors (on www.iQuickItSalivaAnalyzer.com), is the sole and exclusive property of Quick, LLC. Postings are subject to the approval of Quick, LLC, and may be modified, deleted, or redacted, in the sole discretion of Quick, LLC.